CVS Health Reaches $37.8 Million Settlement Over Allegations of Faulty Insulin Refills

Hims & Hers Makes a Bold Move: Pain-Free Blood Tests Head Home

A Landmark Payout: Starbucks Faces Historic $38 Million Penalty in NYC Labor Dispute

The Great American Shopping Spree: Unpacking Black Friday & Thanksgiving's Record-Breaking Kickoff

Eli Lilly's Zepbound Gets a Significant Price Drop: What It Means for Patients and the Market

A Bold Bet on the Future: Regeneron's $150M Investment in Gene Writing

Cloud Giants Unite: Amazon and Google Forge Groundbreaking Partnership to Bulletproof the Internet

Markets Unwrapped: Black Friday Excitement, Silver's Rise, & Tech Showdowns

Federal Judge Deals Blow to New York, Hands Amazon Key Victory in Labor Law Battle

The Future is Now: WeRide and Uber Unleash Driverless Rides in Abu Dhabi

Novo Nordisk's Alzheimer's Trial: A Minor Blip for a Pharma Giant

Wall Street Kicks Off the Week with a Tech-Fueled Surge: The Rate Cut Whisper Grows Louder

Deutsche Bank Strikes Gold: A Remarkable Comeback in Market Forecasting

Navigating the NVIDIA Hype: Is Now the Moment to Invest?

Texas Attorney General Takes On Pharma Giants Sanofi and Bristol Myers Squibb Over Alleged Plavix Warning Failures

A Glimmer of Hope? Novo Nordisk's GLP-1 Drug and the Alzheimer's Enigma

The Jemperli Royalty Rumble: GSK's Tesaro Unit Takes AnaptysBio to Court

Beyond the Noise: Unpacking TCW's Relative Value Approach for Q3 2025—And What It Means for Your Portfolio

The Billion-Dollar Standoff: Pfizer Unleashes on Novo Nordisk in Metsera Bid Battle

The Great Chip Gambit: Trump, Xi, and the Future of AI Supremacy

The Retail Giant Shrinks: Amazon's Staggering 30,000 Job Cut Plan

Huntington's Southern Gambit: A Banking Giant Eyes Cadence and New Horizons

A Remarkable Re-Entry: How GSK's Blenrep Battled Back for a Second Shot at Fighting Myeloma

The Unstoppable Pulse: HCA Healthcare's Surprising Triumph

Novartis' Cosentyx Shines in Long-Term Trial, Offering Hope for Chronic Joint Pain Sufferers

Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership

Omeros Stock Skyrockets: Novo Nordisk Seals Massive $2.1 Billion Rare Disease Drug Deal

Merck's Breakthrough: Islatravir-Doravirine Matches Leading HIV Treatment in Pivotal Trials

Humana's Billion-Dollar Setback: Court Upholds CMS Medicare Advantage Rating Changes

Takeda and Nabla Bio Forge $1 Billion Alliance to Revolutionize Antibody Design with AI

A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients

China's Bold Gambit: New K-Visa Program Ignites Global Talent War Amidst US H-1B Curbs

Warning Bells Ring: The Buffett Indicator Flashes 'Playing with Fire' Levels

AstraZeneca's Bold Leap: Simplifying US Investment with a Direct Nasdaq Listing

BP Unleashes $5 Billion Deepwater Giant in Gulf of Mexico

Market Movers Revealed: Unpacking Last Week's Large-Cap Triumphs!

Biogen's High-Dose Spinraza Hits Regulatory Snag: FDA Issues Refusal to File

Micron's AI Revolution: CEO Sanjay Mehrotra Declares AI the Undeniable Catalyst for Record-Breaking Growth

European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases